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SHV-2 fi-lactamase was purified from an overproducing variant of a clinical isolate of Escherichia coli resistant o cefotax- 
ime. Pure protein was digested by trypsin and Lys-C endoproteinase. Proteolytic peptides, isolated by reverse-phase 
HPLC, were submitted to manual Edman degradation and aligned by homology with the sequence of SHV-1 b-lactamase. 
A putative amino acid sequence was deduced. Structural comparison revealed that SHV-2 differed from SHV-I by only 
one amino acid, Gly -+ Ser, at position 213 of the mature protein. 
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1. INTRODUCTION 
,&Lactamases are bacterial enzymes that confer 
resistance to fi-lactam antibiotics. Plasmid and 
chromosomally-encoded fi-lactamases are numer- 
ous [1,2] and most of penicillins and cephalo- 
sporins are affected by their catalytic activity. So, 
the new methoxy-imino cephalosporins, such as 
cefotaxime, believed to be ‘p-lactamase stable’ an- 
tibiotics, were extensively used in therapy of 
clinical infectious diseases. But, rapid emergence 
of resistance to these broad-spectrum 
cephalosporins was observed in several bacterial 
strains overproducing a chromosomally-mediated 
,&lactamase [3-51. The first report of transferrable 
resistance to cefotaxime in a few bacterial strains 
was published in 1983 [6]. Two years later, in one 
of these strains, the involvement of a plasmid- 
mediated &lactamase capable of hydrolyzing 
cefotaxime and other third-generation cephalo- 
sporins was demonstrated [7]. This ,9-lactamase 
was named SHV-2, as it was closely related to a 
well-known SHV-1 enzyme, on the basis of 
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biochemical studies and DNA hybridization. The 
authors claimed that ‘only a few mutational steps 
can convert an SHV-1 producing strain into a 
strain producing a cefotaxime-hydrolyzing en- 
zyme’. Recently we described the complete amino 
acid sequence of SHV-1 ,&lactamase [8]. Here we 
report structural features of SHV-2 &lactamase 
that buttress the above assumption. 
2. MATERIALS AND METHODS 
2.1. b-Lactamase purification and assay 
Escherichia coli A2302 was a clinical isolate from Tunis [9] 
which produced an SHV-2 ,&lactamase whqse genetic determi- 
nant was carried by a conjugative plasmid (Philippon, personal 
communication). Protein was purified, from a mutant strain 
overproducing the SHV-2 enzyme (Ben Yaghlane, unpublish- 
ed), according to the procedure previously described for SHV-1 
purification [lo]. Enzymatic activity was measured by using a 
microacidimetric method [l 11. One unit of #-lactamase activity 
was defined as the amount of enzyme which hydrolyzed 1 pmol 
of benzyl penicillin at 37°C and pH 7.0. 
2.2. Proteoiytic cleavages and peptide tiolation 
60 nmol of carboxymethylated protein (2 mg/ml, 0.25 M 
NHdHCO3) were digested at an enzyme/substrate ratio of 1: 50 
(w/w) at 37°C for 2 h at pH 8.0 with trypsin (Sigma) or for 20 h 
at pH 9.0 with endoproteinase Lys-C from Lysobacter en- 
zymogenes (Boehringer, Mannheim). Subfractionation of tryp- 
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tic peptide TlO by Staphylococcus aureus V8 protease (Sigma) 
was performed in the same buffer at pH 8.0 at an en- 
zyme/substrate of 1:50 (w/w) for 18 h at 37°C. Peptides 
resulting from cleavages were purified on a 5 ym Nucleosil Cl8 
column (4 x 250 mm), by using an LKB HPLC system, at room 
temperature at a flow rate of 1 ml/min, with 0.1% 
trifluoroacetic acid in water as solvent A and acetonitrile as sol- 
vent B. Tryptic and S. aureus V8 protease digests were 
separated by using a three-step linear gradient of solvent B 
(0 min, 5%; 35 min. 30%; 45 min, 45%; 60 min, 80%). With 
Lys-C endoproteinase digest a linear gradient of solvent B was 
increased from 17% to 55% within 50 min. In some instances 
peptides were further chromatographed at pH 6.0 on the same 
column, with a linear gradient from 0.25 mM ammonium 
acetate buffer to 0.5 mM ammonium acetate buf- 
feriacetonitrile (2 : 3, v/v), within 65 min. Peptides were 
detected at 226 nm. 
2.3. Amino acid and sequence analyses 
Carboxymethylated protein or peptides (l-2 nmol) were 
hydrolyzed at 1 10°C under vacuum with 200 /Al of 6 v HCl for 
23 h. For the larger peptide TlO and protein additional analyses 
were performed for 48 h and 72 h. Amino acids were separated 
as described [i3]. Manual degradation of peptides (2-10 nmol) 
was performed according to the Chang’s double coupling 
method [12] as described by Allen 1131 with slight modifications 
[81. 
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3. RESULTS AND DISCUSSION 
On SDS-gel electrophoresis purified protein 
gave a single band whose mobility corresponded to 
an M, value of 28000 k 500. The first N-terminal 
amino acid degradations each yielded one residue 
with the sequence Ser-Pro-Gln-Pro-Leu-Glu-. 
Pure enzyme showed a specific activity of 
600 U/mg and behaved as SHV-2 P-lactamase [7] 
in kinetic constants and analytical isoelectric 
focusing. The amino acid composition did not dif- 
fer markedly from that of the SHV-1 protein [lo] 
and fitted well with that deduced from the amino 
acid sequence analysis. 
Fig.1. Separation of peptides (18 nmol) after digestion of 
SHV-2 ,!?-lactamase with trypsin. Peptide mixture, adjusted to 
pH 2.0 with trifluoroacetic acid, was applied to a Nucleosil Cl8 
column and eluted as described in section 2. Peptides are 
numbered in the order in which they occur in the sequence, 
starting from the N-terminus. Peptide 20 is the parent fragment 
of peptides 18 and 19. 
From tryptic digestion 24 peptides were 
recovered by reverse-phase HPLC at pH 2.0 
(fig.1). Peaks 1, 3, 8, 11, 14, 17 and 21 were fur- 
ther rechromatographed at pH 6.0. Peptide 19 
which eluted with the buffer peak was separated by 
additional isocratic chromatography at pH 2.0 
with solvent A. After amino acid composition 
determinations all the peptides except TlO were 
fully sequenced by manual Edman degradation 
(fig.2). Primary structure of the 42-residue long 
peptide TlO was elucidated by analysis of subpep- 
tides TlO-Vl, TlO-V3 and TlO-V5 resulting from 
fractionation of the parent peptide by S. aweus VS 
protease. TlO-V5 resulted from an unexpected 
cleavage at a threonine residue. From sequence 
analysis of tryptic peptides, SHV-2 and SHV-1 p- 
lactamases appeared quite related. So, the 24 pep- 
tides yielded by trypsin digestion of the SHV-2 
protein were aligned in fig.2 according to the se- 
quence of the SHV-1 enzyme [8]. No attempt to 
find spanning fragments from another proteolytic 
cleavage was made. However, as tryptic peptides 
corresponding to positions 178-180 and 216-218 
were not recovered, the SHV-2 protein was further 
cleaved by Lys-C endoproteinase and the HPLC 
isolated peptides K5 and K6 were subjected to Ed- 
man degradation. 
From those results we deduced the putative 
amino acid sequence shown in fig.2 and 
demonstrated that SHV-2 ,&lactamase differed 
from the SHV-1 enzyme by one amino acid 
substitution, Cly --+ Ser at position 213. This 
mutation, which may result from a single 
nucleotide base change in DNA structure, allows 
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Fig.2. Putative amino acid sequence of SHV-2 ,&lactamase. T and K indicate peptides derived from digestion with trypsin and Lys-C 
endoproteinase, respectively. TlO-V designate peptides obtained from subfractionation of TlO with S. uure~s V8 protease. Peptide 
alignment was supported by strong homology with the sequence of SHV-1 enzyme [S]. Residues identified by manual Edman 
degradation are underlined by continuous lines. Dotted lines indicate residues only checked by amino acid analysis. Boxing position 
213 holds a glycine residue in SHV-1 amino acid sequence. 
the new SHV-2 P-lactamase to efficiently 
hydrolyze cefotaxime and related compounds. 
Recently [14], it was demonstrated that the CTX-1 
enzyme, another plasmid-mediated ,&lactamase 
with cefotaxime activity [15], differed from the 
TEM-2 enzyme by only two amino acids. The 
substitutions occurred at positions 102 (Glu - 
Lys) and 236 (Gly - Ser) of the unprocessed 
TEM-2 protein, i.e. at positions 79 and 213 of the 
mature enzyme. So, it is likely that residue 213 
must interfere with the active site of these ,& 
lactamases. SHV-1 and TEM enzymes, found to be 
closely related to a chromosomally-mediated & 
lactamase of Klebsiella pneumoniae [8,16], both 
belong to class A as defined in [ 171. Recently, the 
crystal structure of fl-lactamase from S. aureus 
PC1 strain, another class A &lactamase, has been 
reported [ 181. The proposed three-dimensional 
structure of the substrate-enzyme complex allowed 
a direct interaction between an alanine at position 
238 and the side chain of the ,&lactam antibiotic. 
Position 238 of the S. aureus enzyme corresponds 
to position 213 of SHV and TEM ,&lactamases. 
Then, in the same way, residue 213 could interplay 
with the oxime group of cefotaxime bound to the 
active site. In the case of CTX-1 and SHV-2 p- 
lactamases, whose position 213 holds a serine 
residue, a new hydrogen bond may occur in the 
enzyme-substrate complex so that the catalytic ac- 
tivity towards cefotaxime antibiotic may be 
markedly increased. 
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